Concepedia

Publication | Closed Access

Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy

DOI

45

Citations

31

References

2015

Year

Monica Locatelli, Daniela Corna, Sebastian Villa, Daniela Rottoli, Valeria Nava, Roberta Verde, Fabiana Piscitelli, Vincenzo Di Marzo, Juergen Fingerle, Jean-Michel Adam,
˜The œNephron journals/Nephron journals

Abstract

These results suggest that CB2 agonism is a potential option to be added to the available therapeutic armamentarium for type 2 diabetic nephropathy.

References

YearCitations

Page 1